BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 28, 2007
View Archived Issues
Recent patents impart new therapeutic agents for respiratory and allergic disorders
Read More
Novel therapeutic agents for cardiovascular disorders imparted by pSivida
Read More
Novel 5-HT2C antagonist developed at BMS for the treatment of obesity
Read More
Recent patents report new treatments for neuropsychiatric disorders
Read More
New treatment option for urological disorders reported by Takeda
Read More
Mepolizumab lowers blood eosinophils and reduces steroid use in hypereosinophilic syndrome
Read More
Icatibant effective in acute hereditary angioedema attacks
Read More
Andolast prevents bronchoconstriction in asthma patients
Read More
BioMarin recaps Q4 events
Read More
NextPharma signs development agreement with Eucodis
Read More
Plethora plans phase III program for Invicorp in erectile dysfunction
Read More
VGX Pharmaceuticals and Advisys sign merger agreement
Read More
Progress in Avalon and Novartis' drug discovery collaboration
Read More
Lilly plans new phase III trial of Xigris
Read More
Enrollment open in phase III study of Stimuvax for NSCLC
Read More
Merck KGaA holds nearly all voting rights in Merck Serono
Read More
Ortec begins PMA supplement filing for OrCel
Read More
Amazon Biotech preparing phase I/II studies for AMZ-0026
Read More
Bristol-Myers Squibb and Adnexus to develop oncology compounds
Read More
Novelix licenses NVX-207 to AOP Orphan
Read More
Trius acquires rights to Dong-A's oxazolidinone antibacterial compounds
Read More
Phase III study of glufosfamide in pancreatic cancer misses endpoint
Read More
Positive phase I findings for LCP-AtorFen
Read More
Takeda and TAP sign promotion agreement for Amitiza
Read More